The European Commission has approved Saria’s acquisition of sole control over Quintet and Bioiberica, as well as its acquisition of joint control over Teeuwissen and Jagero II. Saria manufactures products using animal and vegetable by-products. Teeuwissen and Jagero II are holding companies involved in commercializing meat for human consumption.
The acquisitions of Teeuwissen and Jagero II create horizontal overlaps in the market for animal by-products in the United Kingdom and France. Yet the Commission found that other competitors, including overseas suppliers, and slaughterhouses pose enough competition so that Saria would not be able to increase prices as a result of the merger.
Source: EC Press Release
Related content: Reform of the EU Merger Regulation: Looking Out for the Minority (Christian Riis-Madsen, Sophia Stephanou & Killian Kehoe, O’Melveny & Myers)
Featured News
US Consumer Watchdog Eyes Expansion of ‘Junk Fee’ Crackdown Ahead of 2024 Election
Oct 10, 2024 by
CPI
Brazil Proposes Reform to Competition Law Targeting Big Tech
Oct 10, 2024 by
CPI
Meta Enhances User Data Control, Resolving German Antitrust Dispute
Oct 10, 2024 by
CPI
X May Be Excluded from EU’s Strict Tech Rules, Sources Suggest
Oct 10, 2024 by
CPI
G7 Targets Competitive Imbalances in Semiconductor Industry
Oct 10, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Refusal to Deal
Sep 27, 2024 by
CPI
Antitrust’s Refusal-to-Deal Doctrine: The Emperor Has No Clothes
Sep 27, 2024 by
Erik Hovenkamp
Why All Antitrust Claims are Refusal to Deal Claims and What that Means for Policy
Sep 27, 2024 by
Ramsi Woodcock
The Aspen Misadventure
Sep 27, 2024 by
Roger Blair & Holly P. Stidham
Refusal to Deal in Antitrust Law: Evolving Jurisprudence and Business Justifications in the Align Technology Case
Sep 27, 2024 by
Timothy Hsieh